Mechanistic Overview of SAVM: Splanchnic Ablation for Volume Management in Heart Failure Patients

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott Vascular; Bayer AG; Boston Scientific Corporation; Axon therapies; Fire 1; NXT; Gradient; Zoll; Eko; Verily; CVRx; Daxor